ACAD
Acadia Pharmaceuticals Inc. · Healthcare
EVP and CFO Mark C. Schneyer sold $60K of Acadia Pharmaceuticals Inc.
Sold$60,140
$22.20Price
2,709Shares
−4%Stake
What ACAD did after the filing
- The stock from Wed, Apr 8 open, $22.85
- −8.3%
- S&P 500, same days
- +9.6%
Measured over 30 trading days, to the May 20 close.
Traded Tue, Apr 7. Filed Tue, Apr 7, 7:57 PM ET, after the close. Returns use the Apr 8 open and the May 20 close. Not investment advice.